Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Burrill & Company

1.Anthem Capital Management   (83%):
News | Current News Back to News Biotech stock deals top $100M July 21, 2003 John George Philadelphia Business Journal Although the cash is not pouring in like it did three years ago, money from private investors is slowly and steadily trickling into the local life-sciences sector. Last week, Immun...
2.Bay City Capital - Principals   (75%):
Kirby Bartlett is Chief Administrative Officer at Bay City Capital where he works on a variety of investing activities. He has been involved in 15 investments, including Chemdex and Lexicon, and in numerous strategic financings and partnerships for portfolio companies such as Reliant Pharmaceutical...
3.GBS Venture Partners :: News and Events   (73%):
CogState Tops $1 Million in Sales for 2004-05 (Up 420% on Previous Year) from Contracts with Companies Such as Pfizer & Roche [4 Jul 2005 16:23] Melbourne-based biotechnology company, CogState, exceeded $1 million in sales for the 2004-2005 year reinforcing Steve Burrill s prediction at BIO 2005 tha...
4.CMEA Team - David Collier   (71%):
David Collier General Partner David Collier, M.D. joined CMEA Ventures as a General Partner in 2001. He currently serves on the Board of Directors of Arcadia Biosciences and Predix Pharmaceuticals, and as board observer at Altus Pharmaceuticals, Bayhill Therapeutics and Biomimetic Therapeutics. Bef...
5.GBS Venture Partners :: News and Events   (55%):
NEWS Sunshine Heart Quarterly In... Pharmaxis Ltd Announces Glo... CogState Announces Restruct... CogState Signs Agreement to... Enrolment Commenced in Arid... Novasys Medical Announces N... ASX Announcement - Clinica... Bronchitol Cystic Fibrosis ... Cortical Pty Ltd Presents M... CogState Signs Ag...
6.EDF Ventures - Press Room   (55%):
January 28, 2003 back Contact: Emerald BioAgriculture Corp. 3125 Sovereign Dr. Suite B Lansing, MI 48911-4240 Phone: (517) 882-7370 Fax: (517) 882-7560 LANSING, Mich., January 28, 2003 - A group led by venture capital investment firms Burrill & Company, San Francisco, and A. M. Pappas and Associates...
7.Welcome to Academy Funds   (52%):
Academy Funds (Academy Ventures) is a family of venture capital funds focused on achieving outstanding investment returns in seed and early-stage companies. The following is a partial list of companies/institutions that have co-invested in and/or partnered with Academy portfolio companies: Advent V...
8.EDF Ventures - Press Room Archive   (51%):
on this page: archived information EDF In The News | Press Releases | Company News | Media Kit | Kudos | EDF Newsletter 12/10/2003 Zyray Wireless wins annual UCSD Connect Most Innovative Product Award 12/2/2003 Alfalight s 14-Pin Diode Lasers Achieve Telcordia Qualification 11/17/2003 ISPs Take on ...
9.Anthem Capital Management   (46%):
News | Current News Back to News Cancer Diagnostics Firm Immunicon Gets $25M Round Four July 11, 2003 Estee Pierce HUNTINGDON VALLEY, PA - Immunicon, a biomedical company focusing on the development and commercialization of cell-based diagnostic and related products, announced it has raised $24.8 m...
10.BCM Technologies : Portfolio : Rejuvenon   (46%):
Select company: CURRENT PORTFOLIO: Agennix EnVivo Pharmaceuticals Fairway Medical Technologies Kardia Therapeutics, Inc. Kryptiq Corporation (acquired RosettaMed) Medical Metrics MithraGen Molecular Logix, Inc. Oncovance Technologies, Inc. PharmaFrontiers Progression Therapeutics Prokaryon Technolo...
11.BCM Technologies : Portfolio : Spectral Genomics   (46%):
Select company: CURRENT PORTFOLIO: Agennix EnVivo Pharmaceuticals Fairway Medical Technologies Kardia Therapeutics, Inc. Kryptiq Corporation (acquired RosettaMed) Medical Metrics MithraGen Molecular Logix, Inc. Oncovance Technologies, Inc. PharmaFrontiers Progression Therapeutics Prokaryon Technolo...
12.Welcome to A. M. Pappas and Associates   (46%):
About Us Our Team Where to Find Us Investment Funds Pappas Ventures Portfolio Companies Investment Criteria News Investor Login Art Pappas and Arthur Klausner to speak at the 8th Annual BioFlorida Conference, October 24-25 in Delray Beach, FL Art Pappas to speak at the Burrill and Company Midwest Li...
13.Welcome to A. M. Pappas and Associates   (46%):
About Us Our Team Where to Find Us Investment Funds Pappas Ventures Portfolio Companies Investment Criteria News Investor Login Art Pappas and Arthur Klausner to speak at the 8th Annual BioFlorida Conference, October 24-25 in Delray Beach, FL Art Pappas to speak at the Burrill and Company Midwest Li...
14.InterWest Partners - Investing in Information Technology & Life Sciences   (45%):
InterWest News InterWest Releases Portfolio News Portfolio Releases Events [ InterWest News - Main ] Biotech's Tough New Taskmasters By Arlene Weintraub in Los Angeles June 3, 2004 Venture capital is flowing again -- with restrictions and a cold eye for results. "You've got to sing for your supper,"...
15.A. M. Pappas and Associates: News   (44%):
About Us Our Team Our Network Where to Find Us Investment Funds Pappas Ventures Portfolio Companies Investment Criteria News Home 2003 Archived News 2004 December 31, 2003 " Old drugs, new life " ( Boston Globe ) December 22, 2003 Dynogen Enters Into Agreement with Mitsubishi Pharma Corporation for ...
16.InterWest Partners - Investing in Information Technology & Life Sciences   (41%):
InterWest News InterWest Releases Portfolio News Portfolio Releases Events Portfolio Releases [ Portfolio Releases - Main ] BioMimetic Pharmaceuticals Announced Today the Closing of a Series C Round of Financing Raising $25.7 Million November 4, 2004 - BioMimetic Pharmaceuticals, a biopharmaceutical...
17.Anthem Capital Management   (40%):
News | Current News Back to News Nucleonics Raises $49.2 Million Series B Round June 20, 2004 Dow Jones & Company MALVERN, PA - Nucleonics Inc., a biotech start-up developing novel RNA interference-based, or RNAi, therapies, announced that it has raised $49.2 million in Series B financing. The ...
18.Delphi Ventures   (38%):
Archived Press Releases 10/17/2000 Cellomics Raises $30M Privately While Waiting To Complete IPO By Brady Huggett Staff Writer of BioWorld Cellomics Inc. completed a $30 million private placement of Series C preferred stock, while another day passed since it filed for an initial public offering in t...
19.KBL Healthcare Ventures - Scynexis Snares $29M   (34%):
Back to News KBL in the News Scynexis Snares $29M Friday, June 21, 2002 Recent corporate spinoff SCYNEXIS Inc. said Thursday, June 20, it raised $29 million in a second round of funding - nine months after its first round and almost two years after securing its freedom from French pharmaceuticals gi...
20.KBL Healthcare Ventures - Scynexis Snares $29M   (34%):
Back to News KBL in the News Scynexis Snares $29M Friday, June 21, 2002 Recent corporate spinoff SCYNEXIS Inc. said Thursday, June 20, it raised $29 million in a second round of funding - nine months after its first round and almost two years after securing its freedom from French pharmaceuticals gi...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others